Cole Schmidtknecht, 22, had insurance but couldn’t afford to refill his asthma inhaler after the cost jumped from $70 to more ...

Alongside her team, the independent drugstore owner and pharmacist fills prescriptions and paperwork. It’s a routine she’s ...

Every policymaker in America wants to lower prescription drug costs. The basic understanding is that drug costs are too high for some patients. How to lower drug costs is equally basic: the drug ...

One complicating factor is manufacturer rebates, which are discounts on prescription list prices provided by drug manufacturers to pharmacy benefit managers, which in turn may share some or all of ...

Pharmacy benefit managers, or PBMs ... The FTC said the rebating practices of the three companies have led to artificially inflated list prices for people. List prices are what a drugmaker initially ...

PBMs “systematically excluded them in favor of identical high list price, highly rebated versions,” the FTC alleges. The Federal Trade Commission sued the three dominant pharmacy-benefit ...

If the suit is successful, it could further drive down costs for patients at the pharmacy counter ... are based on a percentage of a drug’s list price. Essentially, in the case of insulin ...

companies known as pharmacy benefit managers that are owned by UnitedHealth Group, CVS and Cigna. The companies “artificially inflated the list price of insulin drugs, impaired patients ...

Pharmacy benefit managers ... rebating practices of the three companies have led to artificially inflated list prices for people. List prices are what a drugmaker initially sets for a product ...